| Literature DB >> 26596813 |
Jean-Claude Daubert1, Raphaël Martins2, Christophe Leclercq2.
Abstract
Both cardiac resynchronization therapy with a pacemaker (CRT-P) and with a biventricular implantable cardioverter-defibrillator (CRT-D) are electrical treatment modalities validated for the management of chronic heart failure. There is no strong scientific evidence that a CRT-D must be offered to all candidates. Common sense should limit the prescription of these costly and complicated devices. The choice of CRT-P is currently acceptable. A direction to explore could be to downgrade from CRT-D to CRT-P at the time of battery depletion in patients with large reverse remodeling and no ventricular tachycardia and ventricular fibrillation detected.Entities:
Keywords: Cardiac resynchronization therapy; Chronic heart failure; Pacemaker
Mesh:
Year: 2015 PMID: 26596813 DOI: 10.1016/j.ccep.2015.08.016
Source DB: PubMed Journal: Card Electrophysiol Clin ISSN: 1877-9182